Sorafenib in pretreated patients with advanced non-small lung cancer harbouring a K-ras mutation

被引：0
|
作者：
Dingemans, Anne-Marie C. [1 ]
van Wijk, Atie [2 ]
Hochstenbag, Monique [1 ]
Thunnissen, Erik [2 ]
Meulemans, Els [1 ]
Smit, Egbert F. [2 ]
机构：
[1] Maastricht Univ, Med Ctr, Maastricht, Netherlands
[2] VUMC, Amsterdam, Netherlands
来源：
JOURNAL OF THORACIC ONCOLOGY | 2009年 / 4卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S414 / S415
页数：2
相关论文
共 50 条
  • [41] Correlation of K-ras mutation with FDG uptake in lung cancer
    Chaudhry, Muhammad
    Alewine, Christine
    Diaz, Luis
    Wahl, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [42] Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer
    Huang, CL
    Taki, T
    Adachi, M
    Konishi, T
    Higashiyama, M
    Kinoshita, M
    Hadama, T
    Miyake, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 12 (03) : 553 - 563
  • [43] Determination of plasma K-ras mutations in codon 12 in advanced non-small cell lung cancer (NSCLC) patients.: Analysis of its prognostic role
    Sirera, R.
    Camps, C.
    Garcia-Gomez, R.
    Vinolas, N.
    Artal, A.
    Guillot, K.
    Blasco, A.
    Safont, M. J.
    Taron, M.
    Rosell, R.
    EJC SUPPLEMENTS, 2007, 5 (04): : 386 - 386
  • [44] Lovastatin overcomes gefitinib resistance in human non-small cell lung cancer cells with K-Ras mutations
    Park, In Hae
    Kim, Jin Young
    Jung, Jae In
    Han, Ji-Youn
    INVESTIGATIONAL NEW DRUGS, 2010, 28 (06) : 791 - 799
  • [45] Prognostic role of K-Ras mutations in non-small cell lung cancer: Still an issue for open debate
    Neri, Monica
    Cesario, Alfredo
    Granone, Pierluigi
    Dominioni, Lorenzo
    Puntoni, Riccardo
    D'Angelillo, Rolando Maria
    Russo, Patrizia
    LUNG CANCER, 2006, 53 (03) : 393 - 395
  • [46] Lovastatin overcomes gefitinib resistance in human non-small cell lung cancer cells with K-Ras mutations
    In Hae Park
    Jin Young Kim
    Jae In Jung
    Ji-Youn Han
    Investigational New Drugs, 2010, 28 : 791 - 799
  • [47] Sorafenib in non-small cell lung cancer
    Zhang, Jianjun
    Gold, Kathryn A.
    Kim, Edward
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (09) : 1417 - 1426
  • [48] Detection of activated K-ras in non-small cell lung cancer by membrane array: A comparison with direct sequencing
    Chong, Inn-Wen
    Chang, Mei-Yin
    Sheu, Chau-Chyun
    Wang, Cheng-Yuan
    Hwang, Jhi-Jhu
    Huang, Ming-Shyan
    Lin, Shiu-Ru
    ONCOLOGY REPORTS, 2007, 18 (01) : 17 - 24
  • [49] Epidermal Growth Factor Receptor and K-Ras mutations in patients with Non Small Cell Lung Cancer
    Mugalaasi, Hood
    Davies, J.
    Medley, L.
    Talbot, D.
    Butler, R.
    Brito, R.
    JOURNAL OF MEDICAL GENETICS, 2009, 46 : S89 - S89
  • [50] Assessment of Epidermal Growth Factor Receptor and K-Ras Mutation Status in Cytological Stained Smears of Non-Small Cell Lung Cancer Patients: Correlation with Clinical Outcomes
    Lozano, Maria D.
    Zulueta, Javier J.
    Echeveste, Jose I.
    Gurpide, Alfonso
    Seijo, Luis M.
    Martin-Algarra, Salvador
    del Barrio, Anabel
    Pio, Ruben
    Angel Idoate, Miguel
    Labiano, Tania
    Luis Perez-Gracia, Jose
    ONCOLOGIST, 2011, 16 (06): : 877 - 885
12345